selected publications
- Inflammation and mitophagy are mitochondrial checkpoints to aging. Nature communications. 2024 Academic Article GET IT
- Targeting immunogenic cell stress and death for cancer therapy. Nature reviews. Drug discovery. 2024 Review GET IT
- Type I interferon and cancer. Immunological reviews. 2023 Review GET IT
-
Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion.
Cell stem cell.
2023
Academic Article
GET IT
Times cited: 1 - Calreticulin exposure orchestrates innate immunosurveillance. Cancer cell. 2023 Academic Article GET IT
-
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Cell death and differentiation.
2023
Review
GET IT
Times cited: 71 - T cell-independent abscopal responses to radiotherapy. Trends in cancer. 2022 Academic Article GET IT
- Quantitative assessment of mitophagy in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
- Mitochondrial control of inflammation. Nature reviews. Immunology. 2022 Review GET IT
- Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. 2022 GET IT
- RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. 2022 GET IT
- Cytofluorometric assessment of acute cell death responses driven by radiation therapy. 2022 GET IT
- The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells. Oncogenesis. 2021 Academic Article GET IT
-
ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms.
Cell reports.
2020
Academic Article
GET IT
Times cited: 16 -
Macrophage Origin, Metabolic Reprogramming and IL-1 Signaling: Promises and Pitfalls in Lung Cancer.
Cancers.
2019
Review
GET IT
Times cited: 12